Haleon plc (NYSE:HLN) Shares Acquired by HighTower Advisors LLC

HighTower Advisors LLC grew its stake in Haleon plc (NYSE:HLN - Free Report) by 27.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 350,795 shares of the company's stock after buying an additional 74,970 shares during the quarter. HighTower Advisors LLC's holdings in Haleon were worth $3,701,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. CWM LLC grew its position in Haleon by 12.0% during the second quarter. CWM LLC now owns 21,982 shares of the company's stock valued at $182,000 after buying an additional 2,360 shares during the period. Dynamic Advisor Solutions LLC acquired a new stake in shares of Haleon during the 2nd quarter valued at about $86,000. Sequoia Financial Advisors LLC increased its stake in shares of Haleon by 7.4% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 81,943 shares of the company's stock valued at $674,000 after purchasing an additional 5,623 shares in the last quarter. Portside Wealth Group LLC raised its holdings in Haleon by 2.7% in the 2nd quarter. Portside Wealth Group LLC now owns 44,985 shares of the company's stock worth $372,000 after purchasing an additional 1,182 shares during the period. Finally, Blue Trust Inc. boosted its position in Haleon by 30.0% during the second quarter. Blue Trust Inc. now owns 24,734 shares of the company's stock worth $210,000 after purchasing an additional 5,712 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company's stock.

Haleon Price Performance

HLN stock traded down $0.04 during trading on Thursday, hitting $9.73. The stock had a trading volume of 10,505,175 shares, compared to its average volume of 5,380,928. The company's 50-day moving average price is $9.76 and its two-hundred day moving average price is $9.50. Haleon plc has a twelve month low of $7.89 and a twelve month high of $10.80. The stock has a market capitalization of $44.04 billion, a P/E ratio of 28.62, a PEG ratio of 2.92 and a beta of 0.28. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58.

Analyst Ratings Changes

A number of analysts have recently commented on HLN shares. UBS Group upgraded Haleon to a "strong-buy" rating in a research report on Tuesday, October 1st. Morgan Stanley boosted their price target on shares of Haleon from $9.90 to $10.95 and gave the stock an "overweight" rating in a report on Friday, September 20th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Haleon presently has an average rating of "Buy" and an average target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.